Cell Source, Inc. (CLCS)
Cell Source, Inc. is a biotechnology firm dedicated to creating cell-based therapies centered on regulating immune tolerance. The company's flagship innovation is its Veto Cell immune system management technology, an advanced immune tolerance platform capable of selectively suppressing specific immune responses. This Veto Cell technology finds application in numerous areas, including enhancing the acceptance of stem cell transplants for conditions like lymphoma, leukemia, and multiple myeloma. Furthermore, it is utilized in treating end-stage kidney disease, various other non-malignant organ diseases, and a spectrum of both cancerous and non-malignant illnesses. Founded in 2012, Cell Source, Inc. maintains its corporate headquarters in New York, New York.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Cell Source, Inc.
No splits on record
Nothing in CLCS's public trading history: no forward or reverse split has affected the share count.
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $407 | $0 | $860 | $455 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$407 | $0 | -$860 | -$455 | $0 | $0 |
| Gross Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research and Development | $1.18M | $1.9M | $1.58M | $2M | $1.32M | $999K | $2.63M | $725K | $1.48M | $1.37M | $1.22M | $1.82M | $1K | $1K |
| Selling, General, and Administrative | $1.55M | $1.95M | $2.6M | $2.18M | $2.69M | $2.64M | $1.18M | $1.28M | $816K | $952K | $1.1M | $2.24M | $26K | $447 |
| Other | $0 | $0 | $142K | $0 | $1K | $446 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $2.73M | $3.85M | $4.33M | $4.17M | $4.02M | $3.64M | $3.81M | $2.01M | $2.29M | $2.32M | $2.32M | $4.05M | $26K | $2K |
| Operating Income (EBIT) | -$2.73M | -$3.85M | -$4.33M | -$4.17M | -$4.02M | -$3.64M | -$3.81M | -$2.01M | -$2.29M | -$2.32M | -$2.32M | -$4.05M | -$26K | -$2K |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | $2.03M | $1.17M | $1.05M | $992K | $1.36M | $937K | $308K | $479K | $227K | $281K | $36K | $0 | $0 | $0 |
| Interest Income | $0 | $0 | $0 | $992 | $1K | $937 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $9 |
| Other Income (Expense) | -$1.91M | -$923K | -$996K | -$992K | -$1.45M | -$922K | -$670K | -$111K | -$790K | $1.35M | -$184K | -$3K | $0 | $5 |
| Income Before Tax (EBT) | -$4.64M | -$4.77M | -$5.32M | -$5.17M | -$5.47M | -$4.56M | -$4.47M | -$2.12M | -$3.08M | -$968K | -$2.5M | -$4.06M | -$26K | -$2K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $5 |
| Net Income | -$4.64M | -$4.77M | -$5.32M | -$5.17M | -$5.47M | -$4.56M | -$4.47M | -$2.12M | -$3.08M | -$968K | -$2.5M | -$4.06M | -$26K | -$2K |
| Net Income Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Supplementary Data | ||||||||||||||
| EPS | -0.10 | -0.15 | -0.17 | -0.18 | -0.19 | -0.19 | -0.18 | -0.08 | -0.12 | -0.04 | -0.10 | -0.18 | -0.00 | -0.14 |
| Diluted EPS | -0.10 | -0.15 | -0.17 | -0.18 | -0.19 | -0.19 | -0.18 | -0.08 | -0.12 | -0.04 | -0.10 | -0.18 | -0.00 | -0.14 |
| Weighted Average OS | 54.36M | 41.87M | 37.79M | 34.84M | 28.12M | 29.10M | 28.33M | 27.55M | 26.77M | 26.19M | 25.72M | 22.19M | 13.17M | 12,067 |
| EBITDA | -$2.73M | -$3.6M | -$3.89M | $333 | -$93K | $301.25B | -$460K | -$2.01M | -$2.29M | -$3.56M | -$2.32M | -$4.05M | $333K | -$1 |
| EBITDA Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Assets | ||||||||||||||
| Current Assets | ||||||||||||||
| Cash and Cash Equivalents | $462K | $75K | $22K | $223K | $93K | $245K | $28K | $19K | $371K | $4K | $7K | $19K | $19K | $22K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $462K | $75K | $22K | $223K | $93K | $245K | $28K | $19K | $371K | $4K | $7K | $19K | $19K | $22K |
| Accounts Receivable | $0 | $50K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $2K | $1K | $12K | $23K | $17K | $30K | $30K | $8K | $36K | $70K | $135K | $26K | $63K | $0 |
| Total Current Assets | $464K | $287K | $195K | $410K | $314K | $452K | $115K | $66K | $532K | $211K | $338K | $121K | $19K | $22K |
| Long-Term Assets | ||||||||||||||
| Property, Plant & Equipment Net | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $407 | $1K | $2K | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $172.97M | $0 | $0 | $4K | $86.88M | $0 | $0 | $0 | $28K | $0 | $0 | $0 |
| Total Long-Term Assets | $0 | $0 | $172.97M | $0 | $0 | $4K | $86.88M | $0 | $0 | $407 | $30K | $2K | $0 | $0 |
| Other Assets | $0 | $0 | -$172.97B | $0 | $0 | -$4K | -$86.88B | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $464K | $287K | $195K | $410K | $314K | $452K | $115K | $66K | $532K | $211K | $368K | $123K | $19K | $22K |
| Liabilities | ||||||||||||||
| Current Liabilities | ||||||||||||||
| Accounts Payable | $1.21M | $1.89M | $1.47M | $680K | $223K | $193K | $135K | $278K | $202K | $219K | $120K | $415 | $0 | $0 |
| Short-Term Debt | $12.98M | $10.07M | $9.25M | $7.9M | $6.47M | $4.81M | $2.55M | $2.67M | $2.32M | $3.09M | $1.07M | $100K | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $133K | $128K | $125K | $122K | $118K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $3.42M | $0 | $2.77M | $100B | $1.94M | $1.97M | $450B | -$285K | $0 | $0 |
| Other Current Liabilities | $7.51M | $6.05M | $4.12M | $240K | -$573K | $321K | -$2.17M | $1.54M | $2.12M | $1.48M | $4.04M | $2.32M | -$993K | $0 |
| Total Current Liabilities | $22.93M | $19.08M | $15.81M | $13.04M | $10.14M | $8.4M | $5.71M | $4.99M | $5.09M | $6.45M | $6.05M | $3.91M | $7K | $5K |
| Long-Term Liabilities | ||||||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $145K | $0 | $0 | $0 | $44K | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $33K | $0 | $0 | $0 |
| Total Long-Term Liabilities | $0 | $0 | $0 | $0 | $6.69M | $0 | $145K | $2.95M | $2.52M | $3.31M | $76K | $100K | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | -$6.69M | -$5M | $0 | -$2.95M | -$2.52M | -$3.31M | $0 | -$100K | $0 | $0 |
| Total Liabilities | $22.93M | $19.08M | $15.81M | $13.04M | $10.14M | $8.4M | $5.86M | $4.99M | $5.09M | $6.45M | $6.13M | $3.91M | $7K | $5K |
| Stockholders' Equity | ||||||||||||||
| Preferred Stock | $297 | $2K | $2K | $2K | $2K | $1K | $1K | $860 | $644 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $68K | $45K | $40K | $36K | $34K | $33K | $27K | $26K | $25K | $25K | $24K | $24K | $6K | $6K |
| Retained Earnings | -$50.82M | -$46.44M | -$41.67M | -$36.35M | -$31.18M | -$25.71M | -$21.15M | -$16.67M | -$14.55M | -$11.47M | -$10.5M | -$8M | -$31K | -$5K |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$860 | -$644 | $0 | $0 | $0 | $0 | $0 |
| Other Stockholders' Equity | $28.29M | $27.6M | $26.02M | $23.68M | $21.32M | $17.73M | $15.38M | $11.72M | $9.97M | $5.2M | $4.72M | $4.19M | $36K | $17K |
| Total Equity | -$22.46M | -$18.8M | -$15.61M | -$12.63M | -$9.83M | -$7.95M | -$5.74M | -$4.92M | -$4.56M | -$6.24M | -$5.76M | -$3.78M | $11K | $17K |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $464K | $287K | $195K | $410K | $314K | $452K | $115K | $66K | $532K | $211K | $368K | $123K | $19K | $22K |
| Supplementary Data | ||||||||||||||
| Total Debt | $12.98M | $10.07M | $9.25M | $7.9M | $6.47M | $4.81M | $2.6M | $2.67M | $2.32M | $3.09M | $1.27M | $100K | $0 | $0 |
| Net Debt | $12.52M | $9.99M | $9.23M | $7.68M | $6.38M | $4.56M | $2.57M | $2.65M | $1.95M | $3.08M | $1.26M | $81K | -$19K | -$22K |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Operating Activities | ||||||||||||||
| Net Income | -$4.64M | -$4.77M | -$5.32M | -$5.17M | -$5.47M | -$4.56M | -$4.48M | -$2.12M | -$3.08M | -$968K | -$2.5M | -$4.06M | -$26K | -$2K |
| Depreciation & Amortization | $0 | $0 | $381K | $4.18M | $4.02M | $301.25B | $3.81M | $407 | $407 | $860 | $860 | $455 | $358K | $2K |
| Deferred Income Tax | $0 | $0 | $0 | -$285.3B | -$731.5B | -$301.25B | -$14.97B | -$209.66B | -$590K | -$2.87M | -$344K | -$944K | $0 | $0 |
| Stock-Based Compensation | $0 | $288K | $445K | $78K | $419K | $792K | $844K | -$19K | $45K | $115K | $136K | $944K | $0 | $0 |
| Changes in Working Capital: | ||||||||||||||
| Accounts Receivable | $50K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | -$676K | $422K | $787K | $457K | $30K | $58K | -$142K | $76K | -$17K | $99K | $323.85B | $28.48B | $0 | $0 |
| Other Working Capital | $1.79M | $1.34M | $1.43M | $1.11M | $671K | $366K | $712K | $216K | $155K | $856K | -$323.85B | -$28.48B | $0 | $0 |
| Total Working Capital Change | $1.16M | $1.76M | $2.22M | $1.56M | $701K | $423K | $570K | $292K | $138K | $955K | $219K | -$10K | $2K | $0 |
| Other Non-Cash Items | $742K | $326K | -$71K | $285.3B | $731.5B | $571K | $14.97B | $209.66B | $1.2M | $1.27M | $492K | $947K | -$358K | -$2K |
| Net Cash from Operating | -$2.73M | -$2.68M | -$2.35M | -$3.14M | -$3.38M | -$2.77M | -$2.59M | -$2M | -$2.29M | -$1.49M | -$2M | -$3.12M | -$23K | -$2K |
| Investing Activities | ||||||||||||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$3K | $0 | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$2.58B | $0 | $0 |
| Net Cash from Investing | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$3K | $0 | $0 |
| Financing Activities | ||||||||||||||
| Debt Repaid | - | - | -$920K | -$3.3M | -$3.58M | -$2.3M | -$715K | -$500K | -$360K | -$1.45M | - | - | - | - |
| Common Stock Issuance | $485K | $641K | $800K | $0 | $0 | $730K | $1.8T | $1.05T | $2.3T | $0 | $71.4B | $3.01M | $551K | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | -$1.05T | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | -$877.74B | -$741.98B | -$451.28B | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $12K | $111K | -$279K | -$28K | $944K | $877.74B | $741.98B | $451.28B | $0 | $38K | $411K | $3.01M | $0 | $1K |
| Net Cash from Financing | $3.12M | $2.74M | $2.15M | $3.27M | $3.23M | $2.99M | $2.6M | $1.65M | $2.66M | $1.49M | $1.99M | $3.11M | $20K | $1K |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $387K | $52K | -$200K | $130K | -$152K | $217K | $9K | -$352K | $367K | -$3K | -$13K | -$9K | -$3K | -$425 |
| Supplementary Data | ||||||||||||||
| Operating Cash Flow | -$2.73M | -$2.68M | -$2.35M | -$3.14M | -$3.38M | -$2.77M | -$2.59M | -$2M | -$2.29M | -$1.49M | -$2M | -$3.12M | -$23K | -$2K |
| Capital Expenditure | $4 | $0 | $0 | -$4 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$3K | $0 | $0 |
| Free Cash Flow | -$2.73M | -$2.68M | -$2.35M | -$3.14M | -$3.38M | -$2.77M | -$2.59M | -$2M | -$2.29M | -$1.49M | -$2M | -$3.12M | -$23K | -$2K |
| Cash at Beginning | $75K | $22K | $223K | $93K | $245K | $28K | $19K | $371K | $4K | $7K | $19K | $29K | $22K | $587 |
| Cash at End | $462K | $75K | $22K | $223K | $93K | $245K | $28K | $19K | $371K | $4K | $7K | $19K | $19K | $161 |